...
flgt-img

Fulgent Genetics Inc, Common Stock

FLGT

NMQ

$19.58

-$0.66

(-3.26%)

1D
Industry: Health Care Providers & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$619.08M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
218.74K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.51
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$16.56 L
$30.68 H
$19.58

About Fulgent Genetics Inc, Common Stock

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California. more

Industry: Health Care Providers & ServicesSector: Health Care

Returns

Time FrameFLGTSectorS&P500
1-Week Return-2.54%-2.27%-0.57%
1-Month Return6.3%-3.96%1.21%
3-Month Return-12.39%-9.7%7.57%
6-Month Return0.98%-3.37%11.45%
1-Year Return-31.51%3.71%28.48%
3-Year Return-77.48%3.8%29.52%
5-Year Return44.29%39.78%90.66%
10-Year Return113.29%106.91%203.75%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue32.53M421.71M992.58M618.97M289.21M[{"date":"2019-12-31","value":3.28,"profit":true},{"date":"2020-12-31","value":42.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":62.36,"profit":true},{"date":"2023-12-31","value":29.14,"profit":true}]
Cost of Revenue14.11M89.81M215.53M252.07M184.76M[{"date":"2019-12-31","value":5.6,"profit":true},{"date":"2020-12-31","value":35.63,"profit":true},{"date":"2021-12-31","value":85.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.3,"profit":true}]
Gross Profit18.42M331.90M777.05M366.90M104.46M[{"date":"2019-12-31","value":2.37,"profit":true},{"date":"2020-12-31","value":42.71,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":47.22,"profit":true},{"date":"2023-12-31","value":13.44,"profit":true}]
Gross Margin56.63%78.70%78.29%59.28%36.12%[{"date":"2019-12-31","value":71.95,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.47,"profit":true},{"date":"2022-12-31","value":75.32,"profit":true},{"date":"2023-12-31","value":45.89,"profit":true}]
Operating Expenses18.85M41.75M104.34M185.40M171.91M[{"date":"2019-12-31","value":10.17,"profit":true},{"date":"2020-12-31","value":22.52,"profit":true},{"date":"2021-12-31","value":56.28,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.72,"profit":true}]
Operating Income(428.00K)290.16M104.34M178.53M(72.69M)[{"date":"2019-12-31","value":-0.15,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.96,"profit":true},{"date":"2022-12-31","value":61.53,"profit":true},{"date":"2023-12-31","value":-25.05,"profit":false}]
Total Non-Operating Income/Expense1.67M3.05M2.69M11.00M(82.78M)[{"date":"2019-12-31","value":15.22,"profit":true},{"date":"2020-12-31","value":27.76,"profit":true},{"date":"2021-12-31","value":24.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-752.83,"profit":false}]
Pre-Tax Income409.00K291.68M104.34M184.03M(174.09M)[{"date":"2019-12-31","value":0.14,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.77,"profit":true},{"date":"2022-12-31","value":63.09,"profit":true},{"date":"2023-12-31","value":-59.68,"profit":false}]
Income Taxes43.00K72.53M174.79M42.10M1.15M[{"date":"2019-12-31","value":0.02,"profit":true},{"date":"2020-12-31","value":41.5,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.09,"profit":true},{"date":"2023-12-31","value":0.66,"profit":true}]
Income After Taxes366.00K219.15M(70.46M)141.92M(175.24M)[{"date":"2019-12-31","value":0.17,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-32.15,"profit":false},{"date":"2022-12-31","value":64.76,"profit":true},{"date":"2023-12-31","value":-79.96,"profit":false}]
Income From Continuous Operations(411.00K)219.15M506.24M141.92M(64.98M)[{"date":"2019-12-31","value":-0.08,"profit":false},{"date":"2020-12-31","value":43.29,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":28.03,"profit":true},{"date":"2023-12-31","value":-12.84,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income366.00K214.31M104.34M143.40M(167.82M)[{"date":"2019-12-31","value":0.17,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":48.69,"profit":true},{"date":"2022-12-31","value":66.91,"profit":true},{"date":"2023-12-31","value":-78.31,"profit":false}]
EPS (Diluted)0.188.4216.355.70(0.41)[{"date":"2019-12-31","value":1.1,"profit":true},{"date":"2020-12-31","value":51.5,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":34.86,"profit":true},{"date":"2023-12-31","value":-2.51,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

FLGT
Cash Ratio 2.88
Current Ratio 4.41
Quick Ratio 4.30

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

FLGT
ROA (LTM) -4.15%
ROE (LTM) -14.35%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

FLGT
Debt Ratio Lower is generally better. Negative is bad. 0.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.92

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

FLGT
Trailing PE NM
Forward PE 7.94
P/S (TTM) 2.23
P/B 0.54
Price/FCF NM
EV/R 1.49
EV/Ebitda NM
PEG 1.32

FAQs

What is Fulgent Genetics Inc share price today?

Fulgent Genetics Inc (FLGT) share price today is $19.58

Can Indians buy Fulgent Genetics Inc shares?

Yes, Indians can buy shares of Fulgent Genetics Inc (FLGT) on Vested. To buy Fulgent Genetics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in FLGT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Fulgent Genetics Inc be purchased?

Yes, you can purchase fractional shares of Fulgent Genetics Inc (FLGT) via the Vested app. You can start investing in Fulgent Genetics Inc (FLGT) with a minimum investment of $1.

How to invest in Fulgent Genetics Inc shares from India?

You can invest in shares of Fulgent Genetics Inc (FLGT) via Vested in three simple steps:

  • Click on Sign Up or Invest in FLGT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Fulgent Genetics Inc shares
What is Fulgent Genetics Inc 52-week high and low stock price?

The 52-week high price of Fulgent Genetics Inc (FLGT) is $30.68. The 52-week low price of Fulgent Genetics Inc (FLGT) is $16.56.

What is Fulgent Genetics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Fulgent Genetics Inc (FLGT) is

What is Fulgent Genetics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Fulgent Genetics Inc (FLGT) is 0.54

What is Fulgent Genetics Inc dividend yield?

The dividend yield of Fulgent Genetics Inc (FLGT) is 0.00%

What is the Market Cap of Fulgent Genetics Inc?

The market capitalization of Fulgent Genetics Inc (FLGT) is $619.08M

What is Fulgent Genetics Inc’s stock symbol?

The stock symbol (or ticker) of Fulgent Genetics Inc is FLGT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top